Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP28787.RABoxcO3B2M4uZyHg4GM_s7Q0Mm3iNc0t_m4-mjeUd5Zc130_assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP28787.RABoxcO3B2M4uZyHg4GM_s7Q0Mm3iNc0t_m4-mjeUd5Zc130_provenance.
• NP11518.RA0mF1HlDCJ2iQnR0EpX8DOac79-9j_T4xsa4xXTt75AQ130_assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP11518.RA0mF1HlDCJ2iQnR0EpX8DOac79-9j_T4xsa4xXTt75AQ130_provenance.
• NP78967.RAUAofkMQhp9Cmkei6xlEYAjY6Z47w9bh7BKO_yve3sRk130_assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP78967.RAUAofkMQhp9Cmkei6xlEYAjY6Z47w9bh7BKO_yve3sRk130_provenance.
• NP78240.RAGjwTu1jfLUB1yLFmxP7wD9nyEoDfjWLQEQ9wM9kWyhw130_assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP78240.RAGjwTu1jfLUB1yLFmxP7wD9nyEoDfjWLQEQ9wM9kWyhw130_provenance.
• assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP10049.RAg2IdKxuAfg5Zq_q62oLJOyoloh9mFGfYfsWt3ICg9Ro130_assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP10049.RAg2IdKxuAfg5Zq_q62oLJOyoloh9mFGfYfsWt3ICg9Ro130_provenance.
• NP24441.RAS19HqjirvpfnN_jHz1atweDZytw0IMNOBbj7XGF8Yp4130_assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP24441.RAS19HqjirvpfnN_jHz1atweDZytw0IMNOBbj7XGF8Yp4130_provenance.
• NP24442.RAZoQzLN2fQR2_IeZj01_xB4etX2nMlhHV02vyhJBr3Ck130_assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP24442.RAZoQzLN2fQR2_IeZj01_xB4etX2nMlhHV02vyhJBr3Ck130_provenance.
• assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP115941.RAtuw0MWgOboXCnO0Mr4sO8Pr0J6EA4-_XiPM-sIpLkRQ130_assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP115941.RAtuw0MWgOboXCnO0Mr4sO8Pr0J6EA4-_XiPM-sIpLkRQ130_provenance.
• NP52052.RAaW--HQ4ncbwSTP5z9bCMAWJwLu9sTacpIadbCZxcp4Q130_assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP52052.RAaW--HQ4ncbwSTP5z9bCMAWJwLu9sTacpIadbCZxcp4Q130_provenance.
• NP749301.RAAG06NFzp7EnN4eNRb1JvJGpNb_LawW1EWpEhgZ0wXMM130_assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP749301.RAAG06NFzp7EnN4eNRb1JvJGpNb_LawW1EWpEhgZ0wXMM130_provenance.
• NP28878.RAJmn44lOm9380P6wQsP5P7s7-Ca7QEdSZnZUixjG3_wM130_assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP28878.RAJmn44lOm9380P6wQsP5P7s7-Ca7QEdSZnZUixjG3_wM130_provenance.
• NP52050.RAr3uJldbGU4uMPh-CQ7hecAK13DtY-7AusenY7k90U5U130_assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP52050.RAr3uJldbGU4uMPh-CQ7hecAK13DtY-7AusenY7k90U5U130_provenance.
• NP117639.RAEfFWuLY3BGzXPYJ7640iK3RMzAnZTFYOJL-gotnYpCg130_assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP117639.RAEfFWuLY3BGzXPYJ7640iK3RMzAnZTFYOJL-gotnYpCg130_provenance.
• NP307139.RA2jmxTVvlKvD76_3DocAOR-SZNgnaaw4raL-5QRHzoS4130_assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307139.RA2jmxTVvlKvD76_3DocAOR-SZNgnaaw4raL-5QRHzoS4130_provenance.
• NP52051.RALaJq286Q9bwpwJy5DoQnAJSj24vY7LIsMrVnEDR9h2c130_assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP52051.RALaJq286Q9bwpwJy5DoQnAJSj24vY7LIsMrVnEDR9h2c130_provenance.
• NP749302.RAFnMLvcJX0Vd9G76uKNIVpRaQQojwcT_UAaOr5iPAYsk130_assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP749302.RAFnMLvcJX0Vd9G76uKNIVpRaQQojwcT_UAaOr5iPAYsk130_provenance.
• NP151799.RA3hOnZQr8xL8vwDCvU7OpRgWYbx6txFa4U90pMJGYj0o130_assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP151799.RA3hOnZQr8xL8vwDCvU7OpRgWYbx6txFa4U90pMJGYj0o130_provenance.
• NP151800.RA9FdWi0UQ17wSNfRNqE7bScRJ_-ECkw2wXOYjOr2ovmU130_assertion description "[Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP151800.RA9FdWi0UQ17wSNfRNqE7bScRJ_-ECkw2wXOYjOr2ovmU130_provenance.